GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The primary outcome of this study is to assess if the GnRHa administration before cold loop
hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical
procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic
therapy in terms of distension liquid absorption and duration of the procedures.